Business Description
iZafe Group AB
ISIN : SE0003656834
Share Class Description:
FRA:M02: Class BTotal Employee Number:
10Compare
Compare
Traded in other countries / regions
IZAFE B.SwedenM02.Germany IPO Date
2026-03-12Description
iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 22.65 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.4 | |||||
Beneish M-Score | -2.1 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26 | |||||
3-Year EBITDA Growth Rate | 48.2 | |||||
3-Year EPS without NRI Growth Rate | 20.6 | |||||
3-Year FCF Growth Rate | 47 | |||||
3-Year Book Growth Rate | -49.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 102.17 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.53 | |||||
9-Day RSI | 36.55 | |||||
14-Day RSI | 43.09 | |||||
3-1 Month Momentum % | -15.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.53 | |||||
Days Inventory | 279.75 | |||||
Days Sales Outstanding | 52.56 | |||||
Days Payable | 178.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.1 | |||||
Shareholder Yield % | 2.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.27 | |||||
Operating Margin % | -269.84 | |||||
Net Margin % | -273.15 | |||||
EBITDA Margin % | -194.46 | |||||
FCF Margin % | -171.93 | |||||
OCF Margin % | -171.93 | |||||
ROE % | -128.25 | |||||
ROA % | -56.77 | |||||
ROIC % | -54.86 | |||||
3-Year ROIIC % | -43.78 | |||||
ROC (Joel Greenblatt) % | -582.31 | |||||
ROCE % | -80.67 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 19.56 | |||||
PB Ratio | 6.52 | |||||
EV-to-EBIT | -8.07 | |||||
EV-to-EBITDA | -11.19 | |||||
EV-to-Revenue | 21.76 | |||||
EV-to-FCF | -13.6 | |||||
Price-to-GF-Value | 0.85 | |||||
Earnings Yield (Greenblatt) % | -12.39 | |||||
FCF Yield % | -7.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
iZafe Group AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.652 | ||
| EPS (TTM) (€) | -0.005 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 43.09 | ||
| 14-Day ATR (€) | 0.000927 | ||
| 20-Day SMA (€) | 0.03612 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.02 - 0.04 | ||
| Shares Outstanding (Mil) | 406.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
iZafe Group AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
iZafe Group AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-03 | In 131 days | ||
| Second quarter earnings results for 2026 | 2026-09-01 | In 68 days | ||
| General meeting for 2026 | 2026-05-28 11:00 | 0.04 (+0.00%) | ||
| Annual report for 2025 | 2026-05-04 | 0.03 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-28 | 0.04 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-16 | -- | ||
| Third quarter earnings results for 2025 | 2025-11-03 | -- | ||
| Second quarter earnings results for 2025 | 2025-08-29 | -- | ||
| General meeting for 2024 | 2025-05-28 14:00 | -- | ||
| Annual report for 2024 | 2025-04-30 | -- |
Show
Entries
iZafe Group AB Frequently Asked Questions
What is iZafe Group AB(FRA:M02)'s stock price today?
The current price of FRA:M02 is €0.03. The 52 week high of FRA:M02 is €0.04 and 52 week low is €0.02.
When is next earnings date of iZafe Group AB(FRA:M02)?
The next earnings date of iZafe Group AB(FRA:M02) is 2026-09-01.
Does iZafe Group AB(FRA:M02) pay dividends? If so, how much?
iZafe Group AB(FRA:M02) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on iZafe Group AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers